Cargando…
A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2, SARS2) remains a great global health threat and demands identification of more effective and SARS2-targeted antiviral drugs, even with successful development of anti-SARS2 vaccines. Viral replicons have proven to be a rapid, safe, and...
Autores principales: | Liu, Ying, Li, Lu, Timani, Khalid A., He, Johnny J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143625/ https://www.ncbi.nlm.nih.gov/pubmed/35632716 http://dx.doi.org/10.3390/v14050974 |
Ejemplares similares
-
Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation
por: Wang, Bei, et al.
Publicado: (2021) -
Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
por: Nguyen, Hai Trong, et al.
Publicado: (2021) -
Replication and single-cycle delivery of SARS-CoV-2 replicons
por: Ricardo-Lax, Inna, et al.
Publicado: (2021) -
SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021) -
Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
por: Nakamura, Akina, et al.
Publicado: (2022)